Albiglutide liquid auto-injector

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Diabetes Mellitus, Type 2

Phase 1

Bioequivalence Study of Two Albiglutide Drug Products in Healthy Adult Subjects

CompletedNCT02660736

GlaxoSmithKlineDiabetes Mellitus, Type 2

Start: 2016-02-29End: 2016-08-31Updated: 2016-11-09

Phase 3

Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus

CompletedNCT02683746

GlaxoSmithKlineDiabetes Mellitus, Type 2

Start: 2016-03-16End: 2017-05-15Updated: 2019-07-23

Related Papers

A Randomized, Double‐Blind, Single‐Dose, Crossover Study to Demonstrate the Bioequivalence of 2 Formulations of Albiglutide in Healthy Adult Participants

Clinical Pharmacology in Drug Development2018-07-312 citations